nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—ATP4A—coronary artery disease	0.263	0.802	CbGaD
Lansoprazole—CYP2C19—coronary artery disease	0.0646	0.197	CbGaD
Lansoprazole—ABCG2—Telmisartan—coronary artery disease	0.0154	0.0364	CbGbCtD
Lansoprazole—ABCG2—Pitavastatin—coronary artery disease	0.0154	0.0364	CbGbCtD
Lansoprazole—CYP2C8—Fenofibrate—coronary artery disease	0.0136	0.032	CbGbCtD
Lansoprazole—ABCG2—Rosuvastatin—coronary artery disease	0.0114	0.0269	CbGbCtD
Lansoprazole—ABCG2—Ezetimibe—coronary artery disease	0.0114	0.0269	CbGbCtD
Lansoprazole—CYP2C8—Gemfibrozil—coronary artery disease	0.0108	0.0256	CbGbCtD
Lansoprazole—ABCG2—Pravastatin—coronary artery disease	0.0103	0.0244	CbGbCtD
Lansoprazole—ABCB1—Ticagrelor—coronary artery disease	0.0103	0.0243	CbGbCtD
Lansoprazole—CYP2C9—Fenofibrate—coronary artery disease	0.00945	0.0223	CbGbCtD
Lansoprazole—CYP2C8—Clopidogrel—coronary artery disease	0.00939	0.0222	CbGbCtD
Lansoprazole—CYP2C19—Gemfibrozil—coronary artery disease	0.00909	0.0215	CbGbCtD
Lansoprazole—CYP1A2—Gemfibrozil—coronary artery disease	0.00839	0.0198	CbGbCtD
Lansoprazole—CYP2C8—Pitavastatin—coronary artery disease	0.00821	0.0194	CbGbCtD
Lansoprazole—CYP2C19—Clopidogrel—coronary artery disease	0.00788	0.0186	CbGbCtD
Lansoprazole—CYP2C9—Gemfibrozil—coronary artery disease	0.00756	0.0179	CbGbCtD
Lansoprazole—CYP1A2—Clopidogrel—coronary artery disease	0.00727	0.0172	CbGbCtD
Lansoprazole—CYP2C19—Telmisartan—coronary artery disease	0.00689	0.0163	CbGbCtD
Lansoprazole—CYP2C9—Clopidogrel—coronary artery disease	0.00655	0.0155	CbGbCtD
Lansoprazole—ABCB1—Perindopril—coronary artery disease	0.00636	0.015	CbGbCtD
Lansoprazole—ABCB1—Clopidogrel—coronary artery disease	0.00636	0.015	CbGbCtD
Lansoprazole—CYP3A4—Ticagrelor—coronary artery disease	0.00617	0.0146	CbGbCtD
Lansoprazole—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.0059	0.0139	CbGbCtD
Lansoprazole—CYP2C9—Pitavastatin—coronary artery disease	0.00573	0.0135	CbGbCtD
Lansoprazole—CYP2C8—Simvastatin—coronary artery disease	0.00563	0.0133	CbGbCtD
Lansoprazole—CYP2C9—Valsartan—coronary artery disease	0.00557	0.0132	CbGbCtD
Lansoprazole—ABCB1—Pitavastatin—coronary artery disease	0.00556	0.0131	CbGbCtD
Lansoprazole—ABCB1—Telmisartan—coronary artery disease	0.00556	0.0131	CbGbCtD
Lansoprazole—CYP2C19—Timolol—coronary artery disease	0.00555	0.0131	CbGbCtD
Lansoprazole—CYP2C8—Lovastatin—coronary artery disease	0.00551	0.013	CbGbCtD
Lansoprazole—CYP2C8—Pravastatin—coronary artery disease	0.00551	0.013	CbGbCtD
Lansoprazole—CYP3A4—Fenofibrate—coronary artery disease	0.0055	0.013	CbGbCtD
Lansoprazole—ABCB1—Enalapril—coronary artery disease	0.00527	0.0125	CbGbCtD
Lansoprazole—ABCB1—Lisinopril—coronary artery disease	0.00527	0.0125	CbGbCtD
Lansoprazole—CYP2C19—Rosuvastatin—coronary artery disease	0.00508	0.012	CbGbCtD
Lansoprazole—CYP2C8—Atorvastatin—coronary artery disease	0.00502	0.0119	CbGbCtD
Lansoprazole—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00495	0.0117	CbGbCtD
Lansoprazole—CYP2C19—Simvastatin—coronary artery disease	0.00472	0.0112	CbGbCtD
Lansoprazole—CYP2C19—Lovastatin—coronary artery disease	0.00462	0.0109	CbGbCtD
Lansoprazole—CYP2C8—Losartan—coronary artery disease	0.00459	0.0108	CbGbCtD
Lansoprazole—CYP2D6—Niacin—coronary artery disease	0.00454	0.0107	CbGbCtD
Lansoprazole—ABCB1—Timolol—coronary artery disease	0.00448	0.0106	CbGbCtD
Lansoprazole—CYP3A4—Gemfibrozil—coronary artery disease	0.00439	0.0104	CbGbCtD
Lansoprazole—CYP2C9—Rosuvastatin—coronary artery disease	0.00422	0.00998	CbGbCtD
Lansoprazole—CYP2D6—Timolol—coronary artery disease	0.00422	0.00998	CbGbCtD
Lansoprazole—CYP2C19—Atorvastatin—coronary artery disease	0.00421	0.00995	CbGbCtD
Lansoprazole—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00411	0.00973	CbGbCtD
Lansoprazole—ABCB1—Ezetimibe—coronary artery disease	0.0041	0.00969	CbGbCtD
Lansoprazole—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00399	0.00944	CbGbCtD
Lansoprazole—ABCB1—Captopril—coronary artery disease	0.00394	0.00932	CbGbCtD
Lansoprazole—CYP2C9—Simvastatin—coronary artery disease	0.00392	0.00928	CbGbCtD
Lansoprazole—CYP2C19—Losartan—coronary artery disease	0.00385	0.0091	CbGbCtD
Lansoprazole—CYP2C9—Pravastatin—coronary artery disease	0.00384	0.00908	CbGbCtD
Lansoprazole—CYP2C9—Lovastatin—coronary artery disease	0.00384	0.00908	CbGbCtD
Lansoprazole—CYP3A4—Clopidogrel—coronary artery disease	0.00381	0.00901	CbGbCtD
Lansoprazole—ABCB1—Simvastatin—coronary artery disease	0.00381	0.00901	CbGbCtD
Lansoprazole—ABCB1—Pravastatin—coronary artery disease	0.00373	0.00881	CbGbCtD
Lansoprazole—ABCB1—Lovastatin—coronary artery disease	0.00373	0.00881	CbGbCtD
Lansoprazole—CYP2D6—Captopril—coronary artery disease	0.00372	0.00879	CbGbCtD
Lansoprazole—CYP2D6—Simvastatin—coronary artery disease	0.00359	0.00849	CbGbCtD
Lansoprazole—CYP1A2—Losartan—coronary artery disease	0.00355	0.0084	CbGbCtD
Lansoprazole—CYP3A4—Eplerenone—coronary artery disease	0.00354	0.00837	CbGbCtD
Lansoprazole—CYP2D6—Pravastatin—coronary artery disease	0.00351	0.0083	CbGbCtD
Lansoprazole—CYP2D6—Lovastatin—coronary artery disease	0.00351	0.0083	CbGbCtD
Lansoprazole—CYP2C9—Atorvastatin—coronary artery disease	0.0035	0.00827	CbGbCtD
Lansoprazole—ABCB1—Atorvastatin—coronary artery disease	0.00339	0.00803	CbGbCtD
Lansoprazole—CYP2C9—Losartan—coronary artery disease	0.0032	0.00756	CbGbCtD
Lansoprazole—CYP2D6—Atorvastatin—coronary artery disease	0.0032	0.00756	CbGbCtD
Lansoprazole—CYP3A4—Enalapril—coronary artery disease	0.00316	0.00746	CbGbCtD
Lansoprazole—ABCB1—Losartan—coronary artery disease	0.0031	0.00734	CbGbCtD
Lansoprazole—CYP3A4—Rosuvastatin—coronary artery disease	0.00245	0.0058	CbGbCtD
Lansoprazole—CYP3A4—Ezetimibe—coronary artery disease	0.00245	0.0058	CbGbCtD
Lansoprazole—CYP3A4—Simvastatin—coronary artery disease	0.00228	0.0054	CbGbCtD
Lansoprazole—CYP3A4—Pravastatin—coronary artery disease	0.00223	0.00528	CbGbCtD
Lansoprazole—CYP3A4—Lovastatin—coronary artery disease	0.00223	0.00528	CbGbCtD
Lansoprazole—CYP3A4—Atorvastatin—coronary artery disease	0.00203	0.00481	CbGbCtD
Lansoprazole—CYP3A4—Losartan—coronary artery disease	0.00186	0.0044	CbGbCtD
Lansoprazole—CYP2C9—cardial valve—coronary artery disease	0.00107	0.382	CbGeAlD
Lansoprazole—Esomeprazole—ATP4A—coronary artery disease	0.000941	0.264	CrCbGaD
Lansoprazole—Pantoprazole—ATP4A—coronary artery disease	0.00068	0.191	CrCbGaD
Lansoprazole—Rabeprazole—ATP4A—coronary artery disease	0.00068	0.191	CrCbGaD
Lansoprazole—Omeprazole—ATP4A—coronary artery disease	0.000555	0.156	CrCbGaD
Lansoprazole—MAPT—heart—coronary artery disease	0.000293	0.105	CbGeAlD
Lansoprazole—Esomeprazole—CYP2C19—coronary artery disease	0.000232	0.0651	CrCbGaD
Lansoprazole—ATP4A—cardiovascular system—coronary artery disease	0.000205	0.0736	CbGeAlD
Lansoprazole—Rabeprazole—CYP2C19—coronary artery disease	0.000167	0.047	CrCbGaD
Lansoprazole—Pantoprazole—CYP2C19—coronary artery disease	0.000167	0.047	CrCbGaD
Lansoprazole—ATP4A—blood—coronary artery disease	0.000162	0.0582	CbGeAlD
Lansoprazole—Omeprazole—CYP2C19—coronary artery disease	0.000136	0.0384	CrCbGaD
Lansoprazole—CYP1A1—cardiac ventricle—coronary artery disease	9.32e-05	0.0335	CbGeAlD
Lansoprazole—CYP1B1—heart—coronary artery disease	8.66e-05	0.0311	CbGeAlD
Lansoprazole—CYP1B1—cardiovascular system—coronary artery disease	8.17e-05	0.0293	CbGeAlD
Lansoprazole—CYP1B1—blood—coronary artery disease	6.46e-05	0.0232	CbGeAlD
Lansoprazole—ABCG2—heart—coronary artery disease	6.44e-05	0.0231	CbGeAlD
Lansoprazole—CYP1A1—heart—coronary artery disease	6.12e-05	0.022	CbGeAlD
Lansoprazole—CYP2C9—heart—coronary artery disease	5.89e-05	0.0211	CbGeAlD
Lansoprazole—CYP2C19—blood—coronary artery disease	5.67e-05	0.0203	CbGeAlD
Lansoprazole—CYP2C9—cardiovascular system—coronary artery disease	5.56e-05	0.0199	CbGeAlD
Lansoprazole—CYP1A1—cardiac atrium—coronary artery disease	5.23e-05	0.0188	CbGeAlD
Lansoprazole—CYP2C8—blood—coronary artery disease	4.95e-05	0.0178	CbGeAlD
Lansoprazole—ABCG2—blood—coronary artery disease	4.81e-05	0.0173	CbGeAlD
Lansoprazole—CYP1A2—blood—coronary artery disease	4.63e-05	0.0166	CbGeAlD
Lansoprazole—CYP1A1—blood—coronary artery disease	4.57e-05	0.0164	CbGeAlD
Lansoprazole—CYP2C9—blood—coronary artery disease	4.39e-05	0.0158	CbGeAlD
Lansoprazole—CYP3A4—blood—coronary artery disease	3.35e-05	0.012	CbGeAlD
Lansoprazole—CYP2D6—blood—coronary artery disease	3.3e-05	0.0118	CbGeAlD
Lansoprazole—ABCB1—heart—coronary artery disease	3.18e-05	0.0114	CbGeAlD
Lansoprazole—ABCB1—cardiovascular system—coronary artery disease	3e-05	0.0108	CbGeAlD
Lansoprazole—Malaise—Lisinopril—coronary artery disease	2.44e-05	0.000155	CcSEcCtD
Lansoprazole—Oedema—Ramipril—coronary artery disease	2.44e-05	0.000155	CcSEcCtD
Lansoprazole—Anaphylactic shock—Ramipril—coronary artery disease	2.44e-05	0.000155	CcSEcCtD
Lansoprazole—Vertigo—Lisinopril—coronary artery disease	2.43e-05	0.000154	CcSEcCtD
Lansoprazole—Dry mouth—Timolol—coronary artery disease	2.43e-05	0.000154	CcSEcCtD
Lansoprazole—Pain—Losartan—coronary artery disease	2.43e-05	0.000154	CcSEcCtD
Lansoprazole—Constipation—Losartan—coronary artery disease	2.43e-05	0.000154	CcSEcCtD
Lansoprazole—Syncope—Lisinopril—coronary artery disease	2.43e-05	0.000154	CcSEcCtD
Lansoprazole—Vomiting—Eplerenone—coronary artery disease	2.43e-05	0.000154	CcSEcCtD
Lansoprazole—Feeling abnormal—Furosemide—coronary artery disease	2.43e-05	0.000154	CcSEcCtD
Lansoprazole—Leukopenia—Lisinopril—coronary artery disease	2.43e-05	0.000154	CcSEcCtD
Lansoprazole—Nausea—Fenofibrate—coronary artery disease	2.42e-05	0.000153	CcSEcCtD
Lansoprazole—Pruritus—Niacin—coronary artery disease	2.42e-05	0.000153	CcSEcCtD
Lansoprazole—Asthenia—Pravastatin—coronary artery disease	2.41e-05	0.000153	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Furosemide—coronary artery disease	2.41e-05	0.000153	CcSEcCtD
Lansoprazole—Rash—Eplerenone—coronary artery disease	2.41e-05	0.000153	CcSEcCtD
Lansoprazole—Urticaria—Perindopril—coronary artery disease	2.41e-05	0.000153	CcSEcCtD
Lansoprazole—Hypersensitivity—Trandolapril—coronary artery disease	2.41e-05	0.000153	CcSEcCtD
Lansoprazole—Dermatitis—Eplerenone—coronary artery disease	2.41e-05	0.000153	CcSEcCtD
Lansoprazole—Diarrhoea—Valsartan—coronary artery disease	2.41e-05	0.000152	CcSEcCtD
Lansoprazole—Confusional state—Timolol—coronary artery disease	2.4e-05	0.000152	CcSEcCtD
Lansoprazole—Shock—Ramipril—coronary artery disease	2.4e-05	0.000152	CcSEcCtD
Lansoprazole—Hypersensitivity—Enalapril—coronary artery disease	2.4e-05	0.000152	CcSEcCtD
Lansoprazole—Body temperature increased—Perindopril—coronary artery disease	2.4e-05	0.000152	CcSEcCtD
Lansoprazole—Abdominal pain—Perindopril—coronary artery disease	2.4e-05	0.000152	CcSEcCtD
Lansoprazole—Palpitations—Lisinopril—coronary artery disease	2.39e-05	0.000152	CcSEcCtD
Lansoprazole—Diarrhoea—Olmesartan—coronary artery disease	2.39e-05	0.000152	CcSEcCtD
Lansoprazole—Headache—Eplerenone—coronary artery disease	2.39e-05	0.000152	CcSEcCtD
Lansoprazole—Nervous system disorder—Ramipril—coronary artery disease	2.39e-05	0.000152	CcSEcCtD
Lansoprazole—Thrombocytopenia—Ramipril—coronary artery disease	2.39e-05	0.000151	CcSEcCtD
Lansoprazole—Anaphylactic shock—Timolol—coronary artery disease	2.38e-05	0.000151	CcSEcCtD
Lansoprazole—Oedema—Timolol—coronary artery disease	2.38e-05	0.000151	CcSEcCtD
Lansoprazole—Pruritus—Pravastatin—coronary artery disease	2.38e-05	0.000151	CcSEcCtD
Lansoprazole—Loss of consciousness—Lisinopril—coronary artery disease	2.38e-05	0.000151	CcSEcCtD
Lansoprazole—Nausea—Clopidogrel—coronary artery disease	2.38e-05	0.000151	CcSEcCtD
Lansoprazole—Tachycardia—Ramipril—coronary artery disease	2.38e-05	0.000151	CcSEcCtD
Lansoprazole—ABCB1—blood—coronary artery disease	2.37e-05	0.00851	CbGeAlD
Lansoprazole—Skin disorder—Ramipril—coronary artery disease	2.37e-05	0.00015	CcSEcCtD
Lansoprazole—Infection—Timolol—coronary artery disease	2.37e-05	0.00015	CcSEcCtD
Lansoprazole—Vomiting—Simvastatin—coronary artery disease	2.37e-05	0.00015	CcSEcCtD
Lansoprazole—Hypersensitivity—Telmisartan—coronary artery disease	2.37e-05	0.00015	CcSEcCtD
Lansoprazole—Cough—Lisinopril—coronary artery disease	2.36e-05	0.00015	CcSEcCtD
Lansoprazole—Nausea—Lovastatin—coronary artery disease	2.36e-05	0.00015	CcSEcCtD
Lansoprazole—Hyperhidrosis—Ramipril—coronary artery disease	2.36e-05	0.000149	CcSEcCtD
Lansoprazole—Rash—Simvastatin—coronary artery disease	2.35e-05	0.000149	CcSEcCtD
Lansoprazole—Dermatitis—Simvastatin—coronary artery disease	2.35e-05	0.000149	CcSEcCtD
Lansoprazole—Asthenia—Trandolapril—coronary artery disease	2.35e-05	0.000149	CcSEcCtD
Lansoprazole—Shock—Timolol—coronary artery disease	2.34e-05	0.000149	CcSEcCtD
Lansoprazole—Feeling abnormal—Losartan—coronary artery disease	2.34e-05	0.000148	CcSEcCtD
Lansoprazole—Urticaria—Furosemide—coronary artery disease	2.34e-05	0.000148	CcSEcCtD
Lansoprazole—Diarrhoea—Niacin—coronary artery disease	2.34e-05	0.000148	CcSEcCtD
Lansoprazole—Nervous system disorder—Timolol—coronary artery disease	2.34e-05	0.000148	CcSEcCtD
Lansoprazole—Asthenia—Enalapril—coronary artery disease	2.34e-05	0.000148	CcSEcCtD
Lansoprazole—Headache—Simvastatin—coronary artery disease	2.33e-05	0.000148	CcSEcCtD
Lansoprazole—Abdominal pain—Furosemide—coronary artery disease	2.33e-05	0.000148	CcSEcCtD
Lansoprazole—Body temperature increased—Furosemide—coronary artery disease	2.33e-05	0.000148	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Losartan—coronary artery disease	2.33e-05	0.000147	CcSEcCtD
Lansoprazole—Dizziness—Valsartan—coronary artery disease	2.32e-05	0.000147	CcSEcCtD
Lansoprazole—Anorexia—Ramipril—coronary artery disease	2.32e-05	0.000147	CcSEcCtD
Lansoprazole—Nausea—Ezetimibe—coronary artery disease	2.32e-05	0.000147	CcSEcCtD
Lansoprazole—Skin disorder—Timolol—coronary artery disease	2.32e-05	0.000147	CcSEcCtD
Lansoprazole—Dizziness—Olmesartan—coronary artery disease	2.31e-05	0.000147	CcSEcCtD
Lansoprazole—Pruritus—Trandolapril—coronary artery disease	2.31e-05	0.000147	CcSEcCtD
Lansoprazole—Arthralgia—Lisinopril—coronary artery disease	2.31e-05	0.000146	CcSEcCtD
Lansoprazole—Myalgia—Lisinopril—coronary artery disease	2.31e-05	0.000146	CcSEcCtD
Lansoprazole—Chest pain—Lisinopril—coronary artery disease	2.31e-05	0.000146	CcSEcCtD
Lansoprazole—Hyperhidrosis—Timolol—coronary artery disease	2.3e-05	0.000146	CcSEcCtD
Lansoprazole—Asthenia—Telmisartan—coronary artery disease	2.3e-05	0.000146	CcSEcCtD
Lansoprazole—Pruritus—Enalapril—coronary artery disease	2.3e-05	0.000146	CcSEcCtD
Lansoprazole—Diarrhoea—Pravastatin—coronary artery disease	2.3e-05	0.000146	CcSEcCtD
Lansoprazole—Anxiety—Lisinopril—coronary artery disease	2.3e-05	0.000146	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	2.29e-05	0.000145	CcSEcCtD
Lansoprazole—Discomfort—Lisinopril—coronary artery disease	2.28e-05	0.000144	CcSEcCtD
Lansoprazole—Hypotension—Ramipril—coronary artery disease	2.28e-05	0.000144	CcSEcCtD
Lansoprazole—Anorexia—Timolol—coronary artery disease	2.27e-05	0.000144	CcSEcCtD
Lansoprazole—Pruritus—Telmisartan—coronary artery disease	2.27e-05	0.000144	CcSEcCtD
Lansoprazole—Nausea—Eplerenone—coronary artery disease	2.27e-05	0.000144	CcSEcCtD
Lansoprazole—Dizziness—Niacin—coronary artery disease	2.26e-05	0.000143	CcSEcCtD
Lansoprazole—Urticaria—Losartan—coronary artery disease	2.26e-05	0.000143	CcSEcCtD
Lansoprazole—Dry mouth—Lisinopril—coronary artery disease	2.26e-05	0.000143	CcSEcCtD
Lansoprazole—Abdominal pain—Losartan—coronary artery disease	2.25e-05	0.000142	CcSEcCtD
Lansoprazole—Body temperature increased—Losartan—coronary artery disease	2.25e-05	0.000142	CcSEcCtD
Lansoprazole—Asthenia—Captopril—coronary artery disease	2.24e-05	0.000142	CcSEcCtD
Lansoprazole—Diarrhoea—Trandolapril—coronary artery disease	2.24e-05	0.000142	CcSEcCtD
Lansoprazole—Vomiting—Valsartan—coronary artery disease	2.24e-05	0.000142	CcSEcCtD
Lansoprazole—Confusional state—Lisinopril—coronary artery disease	2.23e-05	0.000141	CcSEcCtD
Lansoprazole—Diarrhoea—Enalapril—coronary artery disease	2.23e-05	0.000141	CcSEcCtD
Lansoprazole—Hypotension—Timolol—coronary artery disease	2.23e-05	0.000141	CcSEcCtD
Lansoprazole—Dizziness—Pravastatin—coronary artery disease	2.23e-05	0.000141	CcSEcCtD
Lansoprazole—Vomiting—Olmesartan—coronary artery disease	2.22e-05	0.000141	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.22e-05	0.000141	CcSEcCtD
Lansoprazole—Rash—Valsartan—coronary artery disease	2.22e-05	0.00014	CcSEcCtD
Lansoprazole—Dermatitis—Valsartan—coronary artery disease	2.21e-05	0.00014	CcSEcCtD
Lansoprazole—Nausea—Simvastatin—coronary artery disease	2.21e-05	0.00014	CcSEcCtD
Lansoprazole—Anaphylactic shock—Lisinopril—coronary artery disease	2.21e-05	0.00014	CcSEcCtD
Lansoprazole—Oedema—Lisinopril—coronary artery disease	2.21e-05	0.00014	CcSEcCtD
Lansoprazole—Pruritus—Captopril—coronary artery disease	2.21e-05	0.00014	CcSEcCtD
Lansoprazole—Rash—Olmesartan—coronary artery disease	2.21e-05	0.00014	CcSEcCtD
Lansoprazole—Insomnia—Ramipril—coronary artery disease	2.21e-05	0.00014	CcSEcCtD
Lansoprazole—Dermatitis—Olmesartan—coronary artery disease	2.2e-05	0.00014	CcSEcCtD
Lansoprazole—Headache—Valsartan—coronary artery disease	2.2e-05	0.00014	CcSEcCtD
Lansoprazole—Diarrhoea—Telmisartan—coronary artery disease	2.2e-05	0.000139	CcSEcCtD
Lansoprazole—Infection—Lisinopril—coronary artery disease	2.2e-05	0.000139	CcSEcCtD
Lansoprazole—Headache—Olmesartan—coronary artery disease	2.19e-05	0.000139	CcSEcCtD
Lansoprazole—Paraesthesia—Ramipril—coronary artery disease	2.19e-05	0.000139	CcSEcCtD
Lansoprazole—Shock—Lisinopril—coronary artery disease	2.18e-05	0.000138	CcSEcCtD
Lansoprazole—Asthenia—Perindopril—coronary artery disease	2.17e-05	0.000138	CcSEcCtD
Lansoprazole—Dyspnoea—Ramipril—coronary artery disease	2.17e-05	0.000138	CcSEcCtD
Lansoprazole—Vomiting—Niacin—coronary artery disease	2.17e-05	0.000138	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Timolol—coronary artery disease	2.17e-05	0.000138	CcSEcCtD
Lansoprazole—Hypersensitivity—Furosemide—coronary artery disease	2.17e-05	0.000138	CcSEcCtD
Lansoprazole—Somnolence—Ramipril—coronary artery disease	2.17e-05	0.000137	CcSEcCtD
Lansoprazole—Thrombocytopenia—Lisinopril—coronary artery disease	2.16e-05	0.000137	CcSEcCtD
Lansoprazole—Dizziness—Trandolapril—coronary artery disease	2.16e-05	0.000137	CcSEcCtD
Lansoprazole—Tachycardia—Lisinopril—coronary artery disease	2.16e-05	0.000137	CcSEcCtD
Lansoprazole—Insomnia—Timolol—coronary artery disease	2.16e-05	0.000137	CcSEcCtD
Lansoprazole—Rash—Niacin—coronary artery disease	2.16e-05	0.000137	CcSEcCtD
Lansoprazole—Dermatitis—Niacin—coronary artery disease	2.15e-05	0.000136	CcSEcCtD
Lansoprazole—Dizziness—Enalapril—coronary artery disease	2.15e-05	0.000136	CcSEcCtD
Lansoprazole—Skin disorder—Lisinopril—coronary artery disease	2.15e-05	0.000136	CcSEcCtD
Lansoprazole—Dyspepsia—Ramipril—coronary artery disease	2.15e-05	0.000136	CcSEcCtD
Lansoprazole—Pruritus—Perindopril—coronary artery disease	2.14e-05	0.000136	CcSEcCtD
Lansoprazole—Headache—Niacin—coronary artery disease	2.14e-05	0.000136	CcSEcCtD
Lansoprazole—Paraesthesia—Timolol—coronary artery disease	2.14e-05	0.000136	CcSEcCtD
Lansoprazole—Vomiting—Pravastatin—coronary artery disease	2.14e-05	0.000136	CcSEcCtD
Lansoprazole—Hyperhidrosis—Lisinopril—coronary artery disease	2.14e-05	0.000135	CcSEcCtD
Lansoprazole—Diarrhoea—Captopril—coronary artery disease	2.14e-05	0.000135	CcSEcCtD
Lansoprazole—Dyspnoea—Timolol—coronary artery disease	2.12e-05	0.000135	CcSEcCtD
Lansoprazole—Dizziness—Telmisartan—coronary artery disease	2.12e-05	0.000135	CcSEcCtD
Lansoprazole—Rash—Pravastatin—coronary artery disease	2.12e-05	0.000134	CcSEcCtD
Lansoprazole—Dermatitis—Pravastatin—coronary artery disease	2.12e-05	0.000134	CcSEcCtD
Lansoprazole—Decreased appetite—Ramipril—coronary artery disease	2.12e-05	0.000134	CcSEcCtD
Lansoprazole—Somnolence—Timolol—coronary artery disease	2.12e-05	0.000134	CcSEcCtD
Lansoprazole—Asthenia—Furosemide—coronary artery disease	2.11e-05	0.000134	CcSEcCtD
Lansoprazole—Headache—Pravastatin—coronary artery disease	2.11e-05	0.000134	CcSEcCtD
Lansoprazole—Anorexia—Lisinopril—coronary artery disease	2.11e-05	0.000134	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Ramipril—coronary artery disease	2.1e-05	0.000133	CcSEcCtD
Lansoprazole—Fatigue—Ramipril—coronary artery disease	2.1e-05	0.000133	CcSEcCtD
Lansoprazole—Dyspepsia—Timolol—coronary artery disease	2.1e-05	0.000133	CcSEcCtD
Lansoprazole—Hypersensitivity—Losartan—coronary artery disease	2.09e-05	0.000133	CcSEcCtD
Lansoprazole—Nausea—Valsartan—coronary artery disease	2.09e-05	0.000132	CcSEcCtD
Lansoprazole—Pruritus—Furosemide—coronary artery disease	2.08e-05	0.000132	CcSEcCtD
Lansoprazole—Constipation—Ramipril—coronary artery disease	2.08e-05	0.000132	CcSEcCtD
Lansoprazole—Nausea—Olmesartan—coronary artery disease	2.08e-05	0.000132	CcSEcCtD
Lansoprazole—Vomiting—Trandolapril—coronary artery disease	2.08e-05	0.000132	CcSEcCtD
Lansoprazole—Diarrhoea—Perindopril—coronary artery disease	2.07e-05	0.000131	CcSEcCtD
Lansoprazole—Decreased appetite—Timolol—coronary artery disease	2.07e-05	0.000131	CcSEcCtD
Lansoprazole—Vomiting—Enalapril—coronary artery disease	2.07e-05	0.000131	CcSEcCtD
Lansoprazole—Hypotension—Lisinopril—coronary artery disease	2.07e-05	0.000131	CcSEcCtD
Lansoprazole—Dizziness—Captopril—coronary artery disease	2.06e-05	0.000131	CcSEcCtD
Lansoprazole—Rash—Trandolapril—coronary artery disease	2.06e-05	0.000131	CcSEcCtD
Lansoprazole—Dermatitis—Trandolapril—coronary artery disease	2.06e-05	0.00013	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Timolol—coronary artery disease	2.06e-05	0.00013	CcSEcCtD
Lansoprazole—Fatigue—Timolol—coronary artery disease	2.05e-05	0.00013	CcSEcCtD
Lansoprazole—Rash—Enalapril—coronary artery disease	2.05e-05	0.00013	CcSEcCtD
Lansoprazole—Dermatitis—Enalapril—coronary artery disease	2.05e-05	0.00013	CcSEcCtD
Lansoprazole—Headache—Trandolapril—coronary artery disease	2.05e-05	0.00013	CcSEcCtD
Lansoprazole—Vomiting—Telmisartan—coronary artery disease	2.04e-05	0.000129	CcSEcCtD
Lansoprazole—Asthenia—Losartan—coronary artery disease	2.04e-05	0.000129	CcSEcCtD
Lansoprazole—Headache—Enalapril—coronary artery disease	2.04e-05	0.000129	CcSEcCtD
Lansoprazole—Pain—Timolol—coronary artery disease	2.04e-05	0.000129	CcSEcCtD
Lansoprazole—Nausea—Niacin—coronary artery disease	2.03e-05	0.000129	CcSEcCtD
Lansoprazole—Rash—Telmisartan—coronary artery disease	2.02e-05	0.000128	CcSEcCtD
Lansoprazole—Dermatitis—Telmisartan—coronary artery disease	2.02e-05	0.000128	CcSEcCtD
Lansoprazole—Diarrhoea—Furosemide—coronary artery disease	2.02e-05	0.000128	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.01e-05	0.000128	CcSEcCtD
Lansoprazole—Pruritus—Losartan—coronary artery disease	2.01e-05	0.000127	CcSEcCtD
Lansoprazole—Headache—Telmisartan—coronary artery disease	2.01e-05	0.000127	CcSEcCtD
Lansoprazole—Feeling abnormal—Ramipril—coronary artery disease	2.01e-05	0.000127	CcSEcCtD
Lansoprazole—Dizziness—Perindopril—coronary artery disease	2e-05	0.000127	CcSEcCtD
Lansoprazole—Insomnia—Lisinopril—coronary artery disease	2e-05	0.000127	CcSEcCtD
Lansoprazole—Nausea—Pravastatin—coronary artery disease	2e-05	0.000127	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Ramipril—coronary artery disease	1.99e-05	0.000126	CcSEcCtD
Lansoprazole—Paraesthesia—Lisinopril—coronary artery disease	1.99e-05	0.000126	CcSEcCtD
Lansoprazole—Vomiting—Captopril—coronary artery disease	1.99e-05	0.000126	CcSEcCtD
Lansoprazole—Dyspnoea—Lisinopril—coronary artery disease	1.97e-05	0.000125	CcSEcCtD
Lansoprazole—Rash—Captopril—coronary artery disease	1.97e-05	0.000125	CcSEcCtD
Lansoprazole—Dermatitis—Captopril—coronary artery disease	1.97e-05	0.000125	CcSEcCtD
Lansoprazole—Somnolence—Lisinopril—coronary artery disease	1.97e-05	0.000125	CcSEcCtD
Lansoprazole—Feeling abnormal—Timolol—coronary artery disease	1.96e-05	0.000124	CcSEcCtD
Lansoprazole—Headache—Captopril—coronary artery disease	1.96e-05	0.000124	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Timolol—coronary artery disease	1.95e-05	0.000124	CcSEcCtD
Lansoprazole—Dizziness—Furosemide—coronary artery disease	1.95e-05	0.000123	CcSEcCtD
Lansoprazole—Dyspepsia—Lisinopril—coronary artery disease	1.95e-05	0.000123	CcSEcCtD
Lansoprazole—Diarrhoea—Losartan—coronary artery disease	1.95e-05	0.000123	CcSEcCtD
Lansoprazole—Nausea—Trandolapril—coronary artery disease	1.94e-05	0.000123	CcSEcCtD
Lansoprazole—Urticaria—Ramipril—coronary artery disease	1.94e-05	0.000123	CcSEcCtD
Lansoprazole—Nausea—Enalapril—coronary artery disease	1.93e-05	0.000123	CcSEcCtD
Lansoprazole—Vomiting—Perindopril—coronary artery disease	1.93e-05	0.000122	CcSEcCtD
Lansoprazole—Abdominal pain—Ramipril—coronary artery disease	1.93e-05	0.000122	CcSEcCtD
Lansoprazole—Body temperature increased—Ramipril—coronary artery disease	1.93e-05	0.000122	CcSEcCtD
Lansoprazole—Decreased appetite—Lisinopril—coronary artery disease	1.92e-05	0.000122	CcSEcCtD
Lansoprazole—Rash—Perindopril—coronary artery disease	1.91e-05	0.000121	CcSEcCtD
Lansoprazole—Dermatitis—Perindopril—coronary artery disease	1.91e-05	0.000121	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Lisinopril—coronary artery disease	1.91e-05	0.000121	CcSEcCtD
Lansoprazole—Nausea—Telmisartan—coronary artery disease	1.91e-05	0.000121	CcSEcCtD
Lansoprazole—Fatigue—Lisinopril—coronary artery disease	1.91e-05	0.000121	CcSEcCtD
Lansoprazole—Headache—Perindopril—coronary artery disease	1.9e-05	0.00012	CcSEcCtD
Lansoprazole—Urticaria—Timolol—coronary artery disease	1.89e-05	0.00012	CcSEcCtD
Lansoprazole—Pain—Lisinopril—coronary artery disease	1.89e-05	0.00012	CcSEcCtD
Lansoprazole—Constipation—Lisinopril—coronary artery disease	1.89e-05	0.00012	CcSEcCtD
Lansoprazole—Abdominal pain—Timolol—coronary artery disease	1.88e-05	0.000119	CcSEcCtD
Lansoprazole—Body temperature increased—Timolol—coronary artery disease	1.88e-05	0.000119	CcSEcCtD
Lansoprazole—Dizziness—Losartan—coronary artery disease	1.88e-05	0.000119	CcSEcCtD
Lansoprazole—Vomiting—Furosemide—coronary artery disease	1.87e-05	0.000119	CcSEcCtD
Lansoprazole—Rash—Furosemide—coronary artery disease	1.86e-05	0.000118	CcSEcCtD
Lansoprazole—Dermatitis—Furosemide—coronary artery disease	1.86e-05	0.000118	CcSEcCtD
Lansoprazole—Nausea—Captopril—coronary artery disease	1.85e-05	0.000118	CcSEcCtD
Lansoprazole—Headache—Furosemide—coronary artery disease	1.85e-05	0.000117	CcSEcCtD
Lansoprazole—Feeling abnormal—Lisinopril—coronary artery disease	1.82e-05	0.000115	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Lisinopril—coronary artery disease	1.81e-05	0.000115	CcSEcCtD
Lansoprazole—Vomiting—Losartan—coronary artery disease	1.81e-05	0.000115	CcSEcCtD
Lansoprazole—Nausea—Perindopril—coronary artery disease	1.8e-05	0.000114	CcSEcCtD
Lansoprazole—Hypersensitivity—Ramipril—coronary artery disease	1.8e-05	0.000114	CcSEcCtD
Lansoprazole—Rash—Losartan—coronary artery disease	1.79e-05	0.000114	CcSEcCtD
Lansoprazole—Dermatitis—Losartan—coronary artery disease	1.79e-05	0.000114	CcSEcCtD
Lansoprazole—Headache—Losartan—coronary artery disease	1.78e-05	0.000113	CcSEcCtD
Lansoprazole—Urticaria—Lisinopril—coronary artery disease	1.76e-05	0.000111	CcSEcCtD
Lansoprazole—Hypersensitivity—Timolol—coronary artery disease	1.76e-05	0.000111	CcSEcCtD
Lansoprazole—Nausea—Furosemide—coronary artery disease	1.75e-05	0.000111	CcSEcCtD
Lansoprazole—Asthenia—Ramipril—coronary artery disease	1.75e-05	0.000111	CcSEcCtD
Lansoprazole—Abdominal pain—Lisinopril—coronary artery disease	1.75e-05	0.000111	CcSEcCtD
Lansoprazole—Body temperature increased—Lisinopril—coronary artery disease	1.75e-05	0.000111	CcSEcCtD
Lansoprazole—Pruritus—Ramipril—coronary artery disease	1.72e-05	0.000109	CcSEcCtD
Lansoprazole—Asthenia—Timolol—coronary artery disease	1.71e-05	0.000108	CcSEcCtD
Lansoprazole—Nausea—Losartan—coronary artery disease	1.69e-05	0.000107	CcSEcCtD
Lansoprazole—Pruritus—Timolol—coronary artery disease	1.69e-05	0.000107	CcSEcCtD
Lansoprazole—Diarrhoea—Ramipril—coronary artery disease	1.67e-05	0.000106	CcSEcCtD
Lansoprazole—Diarrhoea—Timolol—coronary artery disease	1.63e-05	0.000103	CcSEcCtD
Lansoprazole—Hypersensitivity—Lisinopril—coronary artery disease	1.63e-05	0.000103	CcSEcCtD
Lansoprazole—Dizziness—Ramipril—coronary artery disease	1.61e-05	0.000102	CcSEcCtD
Lansoprazole—Asthenia—Lisinopril—coronary artery disease	1.59e-05	0.000101	CcSEcCtD
Lansoprazole—Dizziness—Timolol—coronary artery disease	1.58e-05	9.99e-05	CcSEcCtD
Lansoprazole—Pruritus—Lisinopril—coronary artery disease	1.56e-05	9.91e-05	CcSEcCtD
Lansoprazole—Vomiting—Ramipril—coronary artery disease	1.55e-05	9.82e-05	CcSEcCtD
Lansoprazole—Rash—Ramipril—coronary artery disease	1.54e-05	9.74e-05	CcSEcCtD
Lansoprazole—Dermatitis—Ramipril—coronary artery disease	1.54e-05	9.73e-05	CcSEcCtD
Lansoprazole—Headache—Ramipril—coronary artery disease	1.53e-05	9.68e-05	CcSEcCtD
Lansoprazole—Vomiting—Timolol—coronary artery disease	1.52e-05	9.6e-05	CcSEcCtD
Lansoprazole—Diarrhoea—Lisinopril—coronary artery disease	1.51e-05	9.59e-05	CcSEcCtD
Lansoprazole—Rash—Timolol—coronary artery disease	1.5e-05	9.52e-05	CcSEcCtD
Lansoprazole—Dermatitis—Timolol—coronary artery disease	1.5e-05	9.51e-05	CcSEcCtD
Lansoprazole—Headache—Timolol—coronary artery disease	1.49e-05	9.46e-05	CcSEcCtD
Lansoprazole—Dizziness—Lisinopril—coronary artery disease	1.46e-05	9.27e-05	CcSEcCtD
Lansoprazole—Nausea—Ramipril—coronary artery disease	1.45e-05	9.18e-05	CcSEcCtD
Lansoprazole—Nausea—Timolol—coronary artery disease	1.42e-05	8.97e-05	CcSEcCtD
Lansoprazole—Vomiting—Lisinopril—coronary artery disease	1.41e-05	8.91e-05	CcSEcCtD
Lansoprazole—Rash—Lisinopril—coronary artery disease	1.39e-05	8.83e-05	CcSEcCtD
Lansoprazole—Dermatitis—Lisinopril—coronary artery disease	1.39e-05	8.83e-05	CcSEcCtD
Lansoprazole—Headache—Lisinopril—coronary artery disease	1.39e-05	8.78e-05	CcSEcCtD
Lansoprazole—Nausea—Lisinopril—coronary artery disease	1.31e-05	8.32e-05	CcSEcCtD
Lansoprazole—CYP1A2—Metabolism—LIPC—coronary artery disease	1.91e-06	2.23e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HBA1—coronary artery disease	1.91e-06	2.23e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP2C19—coronary artery disease	1.91e-06	2.23e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	1.91e-06	2.23e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ABCA1—coronary artery disease	1.9e-06	2.22e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HADHA—coronary artery disease	1.9e-06	2.21e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOC3—coronary artery disease	1.9e-06	2.21e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—LDLR—coronary artery disease	1.88e-06	2.2e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.88e-06	2.2e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTA1—coronary artery disease	1.87e-06	2.19e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SLC9A1—coronary artery disease	1.86e-06	2.17e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GSTT1—coronary artery disease	1.86e-06	2.17e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—NOS3—coronary artery disease	1.86e-06	2.17e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GSTM1—coronary artery disease	1.86e-06	2.17e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ABCA1—coronary artery disease	1.86e-06	2.17e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GSTP1—coronary artery disease	1.86e-06	2.17e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—LPA—coronary artery disease	1.85e-06	2.16e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GGT1—coronary artery disease	1.84e-06	2.15e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GOT1—coronary artery disease	1.84e-06	2.15e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GCLC—coronary artery disease	1.84e-06	2.15e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CETP—coronary artery disease	1.84e-06	2.15e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	1.84e-06	2.15e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—HMOX1—coronary artery disease	1.83e-06	2.14e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—LPL—coronary artery disease	1.83e-06	2.13e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SDC1—coronary artery disease	1.82e-06	2.12e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PLCB1—coronary artery disease	1.81e-06	2.11e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CAT—coronary artery disease	1.81e-06	2.11e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GOT1—coronary artery disease	1.8e-06	2.1e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GGT1—coronary artery disease	1.8e-06	2.1e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PLCB3—coronary artery disease	1.79e-06	2.1e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PLCB1—coronary artery disease	1.79e-06	2.09e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GPX1—coronary artery disease	1.78e-06	2.08e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOA5—coronary artery disease	1.78e-06	2.07e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ALB—coronary artery disease	1.77e-06	2.07e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.76e-06	2.05e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—APOB—coronary artery disease	1.75e-06	2.05e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ABCA1—coronary artery disease	1.75e-06	2.04e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—P4HB—coronary artery disease	1.74e-06	2.03e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ABCA1—coronary artery disease	1.74e-06	2.03e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CD36—coronary artery disease	1.73e-06	2.03e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PSMB5—coronary artery disease	1.72e-06	2.01e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PSMA6—coronary artery disease	1.72e-06	2.01e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.72e-06	2e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PPP2CA—coronary artery disease	1.71e-06	2e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	1.71e-06	2e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GSTM1—coronary artery disease	1.71e-06	1.99e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTGS2—coronary artery disease	1.7e-06	1.99e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GOT1—coronary artery disease	1.7e-06	1.98e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GGT1—coronary artery disease	1.7e-06	1.98e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—NOS3—coronary artery disease	1.69e-06	1.98e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GGT1—coronary artery disease	1.68e-06	1.96e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GOT1—coronary artery disease	1.68e-06	1.96e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CTGF—coronary artery disease	1.68e-06	1.96e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—LPL—coronary artery disease	1.67e-06	1.95e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GOT2—coronary artery disease	1.66e-06	1.94e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HMGCR—coronary artery disease	1.66e-06	1.94e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GSTP1—coronary artery disease	1.66e-06	1.93e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—MTHFR—coronary artery disease	1.64e-06	1.92e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	1.64e-06	1.92e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—HMOX1—coronary artery disease	1.63e-06	1.91e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GPX1—coronary artery disease	1.63e-06	1.91e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PIK3CA—coronary artery disease	1.63e-06	1.9e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GSTP1—coronary artery disease	1.62e-06	1.89e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—VCAN—coronary artery disease	1.61e-06	1.88e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CAT—coronary artery disease	1.61e-06	1.88e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PPARGC1A—coronary artery disease	1.6e-06	1.87e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALDOA—coronary artery disease	1.6e-06	1.87e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—HMOX1—coronary artery disease	1.59e-06	1.86e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CD36—coronary artery disease	1.59e-06	1.86e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CAT—coronary artery disease	1.57e-06	1.84e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PPP2CA—coronary artery disease	1.57e-06	1.83e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—APOB—coronary artery disease	1.56e-06	1.83e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—AGT—coronary artery disease	1.56e-06	1.82e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—DCN—coronary artery disease	1.55e-06	1.81e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTGS2—coronary artery disease	1.55e-06	1.81e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PLCB1—coronary artery disease	1.53e-06	1.79e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—APOE—coronary artery disease	1.53e-06	1.79e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—APOB—coronary artery disease	1.53e-06	1.78e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GSTP1—coronary artery disease	1.52e-06	1.78e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GSTM1—coronary artery disease	1.52e-06	1.78e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—APOA1—coronary artery disease	1.51e-06	1.77e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALDH2—coronary artery disease	1.51e-06	1.76e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GSTP1—coronary artery disease	1.51e-06	1.76e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	1.51e-06	1.76e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—MTHFR—coronary artery disease	1.51e-06	1.76e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—HMOX1—coronary artery disease	1.5e-06	1.75e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.5e-06	1.75e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	1.5e-06	1.75e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—LPL—coronary artery disease	1.49e-06	1.74e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—HMOX1—coronary artery disease	1.49e-06	1.74e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GSTM1—coronary artery disease	1.49e-06	1.73e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ABCA1—coronary artery disease	1.48e-06	1.73e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CAT—coronary artery disease	1.48e-06	1.73e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—LIPC—coronary artery disease	1.47e-06	1.72e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HBA1—coronary artery disease	1.47e-06	1.72e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP2C19—coronary artery disease	1.47e-06	1.72e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	1.47e-06	1.72e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CAT—coronary artery disease	1.47e-06	1.72e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOC3—coronary artery disease	1.46e-06	1.71e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—LPL—coronary artery disease	1.46e-06	1.7e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GPX1—coronary artery disease	1.46e-06	1.7e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—LDLR—coronary artery disease	1.45e-06	1.7e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.45e-06	1.69e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APOB—coronary artery disease	1.44e-06	1.68e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SLC9A1—coronary artery disease	1.44e-06	1.68e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTT1—coronary artery disease	1.44e-06	1.68e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GOT1—coronary artery disease	1.44e-06	1.68e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GGT1—coronary artery disease	1.44e-06	1.68e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—AGT—coronary artery disease	1.43e-06	1.67e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APOB—coronary artery disease	1.43e-06	1.67e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GPX1—coronary artery disease	1.42e-06	1.66e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PIK3CA—coronary artery disease	1.42e-06	1.66e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GCLC—coronary artery disease	1.42e-06	1.66e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CETP—coronary artery disease	1.42e-06	1.66e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CD36—coronary artery disease	1.42e-06	1.66e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SDC1—coronary artery disease	1.4e-06	1.64e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—APOE—coronary artery disease	1.4e-06	1.64e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PPP2CA—coronary artery disease	1.4e-06	1.64e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GSTM1—coronary artery disease	1.4e-06	1.63e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GSTM1—coronary artery disease	1.39e-06	1.62e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—APOA1—coronary artery disease	1.39e-06	1.62e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CD36—coronary artery disease	1.39e-06	1.62e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—LPL—coronary artery disease	1.37e-06	1.6e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PPP2CA—coronary artery disease	1.37e-06	1.6e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—LPL—coronary artery disease	1.36e-06	1.59e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—MTHFR—coronary artery disease	1.35e-06	1.57e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GPX1—coronary artery disease	1.34e-06	1.57e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PPARG—coronary artery disease	1.33e-06	1.56e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GPX1—coronary artery disease	1.33e-06	1.55e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.33e-06	1.55e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—AKT1—coronary artery disease	1.33e-06	1.55e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.33e-06	1.55e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.33e-06	1.55e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—POMC—coronary artery disease	1.31e-06	1.53e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—MTHFR—coronary artery disease	1.31e-06	1.53e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CD36—coronary artery disease	1.31e-06	1.52e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CTGF—coronary artery disease	1.3e-06	1.51e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CD36—coronary artery disease	1.29e-06	1.51e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GSTP1—coronary artery disease	1.29e-06	1.51e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PPP2CA—coronary artery disease	1.29e-06	1.51e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.28e-06	1.5e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GOT2—coronary artery disease	1.28e-06	1.5e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	1.28e-06	1.49e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PPP2CA—coronary artery disease	1.28e-06	1.49e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—AGT—coronary artery disease	1.28e-06	1.49e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HMOX1—coronary artery disease	1.27e-06	1.49e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CAT—coronary artery disease	1.26e-06	1.47e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—APOE—coronary artery disease	1.25e-06	1.46e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—AGT—coronary artery disease	1.25e-06	1.46e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—APOA1—coronary artery disease	1.24e-06	1.45e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.24e-06	1.44e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—MTHFR—coronary artery disease	1.23e-06	1.43e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—APOE—coronary artery disease	1.22e-06	1.43e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PPARG—coronary artery disease	1.22e-06	1.43e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOB—coronary artery disease	1.22e-06	1.42e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—APOA1—coronary artery disease	1.21e-06	1.41e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—POMC—coronary artery disease	1.21e-06	1.41e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ALB—coronary artery disease	1.2e-06	1.4e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GSTM1—coronary artery disease	1.19e-06	1.38e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.19e-06	1.38e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.18e-06	1.38e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—AGT—coronary artery disease	1.18e-06	1.37e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—AGT—coronary artery disease	1.17e-06	1.36e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—LPL—coronary artery disease	1.16e-06	1.36e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—AKT1—coronary artery disease	1.16e-06	1.36e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APOE—coronary artery disease	1.15e-06	1.34e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—NOS3—coronary artery disease	1.15e-06	1.34e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.14e-06	1.34e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APOE—coronary artery disease	1.14e-06	1.33e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APOA1—coronary artery disease	1.14e-06	1.33e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GPX1—coronary artery disease	1.14e-06	1.33e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APOA1—coronary artery disease	1.13e-06	1.32e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GOT1—coronary artery disease	1.11e-06	1.29e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GGT1—coronary artery disease	1.11e-06	1.29e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CD36—coronary artery disease	1.11e-06	1.29e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ALB—coronary artery disease	1.1e-06	1.28e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PPP2CA—coronary artery disease	1.09e-06	1.28e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PPARG—coronary artery disease	1.09e-06	1.27e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.08e-06	1.26e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—POMC—coronary artery disease	1.08e-06	1.26e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PPARG—coronary artery disease	1.06e-06	1.24e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—NOS3—coronary artery disease	1.05e-06	1.23e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—POMC—coronary artery disease	1.05e-06	1.23e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTGS2—coronary artery disease	1.05e-06	1.22e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—MTHFR—coronary artery disease	1.05e-06	1.22e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PIK3CA—coronary artery disease	1.05e-06	1.22e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PPARG—coronary artery disease	1e-06	1.17e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTP1—coronary artery disease	9.96e-07	1.16e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—AGT—coronary artery disease	9.96e-07	1.16e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PPARG—coronary artery disease	9.95e-07	1.16e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—POMC—coronary artery disease	9.89e-07	1.16e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	9.87e-07	1.15e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HMOX1—coronary artery disease	9.82e-07	1.15e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—POMC—coronary artery disease	9.81e-07	1.15e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ALB—coronary artery disease	9.81e-07	1.15e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOE—coronary artery disease	9.76e-07	1.14e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CAT—coronary artery disease	9.69e-07	1.13e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOA1—coronary artery disease	9.65e-07	1.13e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTGS2—coronary artery disease	9.61e-07	1.12e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ALB—coronary artery disease	9.57e-07	1.12e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PIK3CA—coronary artery disease	9.53e-07	1.11e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOB—coronary artery disease	9.41e-07	1.1e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—NOS3—coronary artery disease	9.38e-07	1.1e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	9.24e-07	1.08e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—NOS3—coronary artery disease	9.16e-07	1.07e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTM1—coronary artery disease	9.15e-07	1.07e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ALB—coronary artery disease	9.02e-07	1.05e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—LPL—coronary artery disease	8.98e-07	1.05e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ALB—coronary artery disease	8.94e-07	1.04e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GPX1—coronary artery disease	8.76e-07	1.02e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—NOS3—coronary artery disease	8.63e-07	1.01e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTGS2—coronary artery disease	8.58e-07	1e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—AKT1—coronary artery disease	8.56e-07	9.99e-06	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—NOS3—coronary artery disease	8.55e-07	9.99e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CD36—coronary artery disease	8.54e-07	9.97e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PPARG—coronary artery disease	8.5e-07	9.92e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPP2CA—coronary artery disease	8.43e-07	9.84e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—POMC—coronary artery disease	8.38e-07	9.79e-06	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTGS2—coronary artery disease	8.37e-07	9.78e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—MTHFR—coronary artery disease	8.09e-07	9.44e-06	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTGS2—coronary artery disease	7.89e-07	9.21e-06	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTGS2—coronary artery disease	7.82e-07	9.14e-06	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—AKT1—coronary artery disease	7.79e-07	9.09e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AGT—coronary artery disease	7.69e-07	8.97e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ALB—coronary artery disease	7.64e-07	8.92e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOE—coronary artery disease	7.53e-07	8.79e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOA1—coronary artery disease	7.44e-07	8.69e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NOS3—coronary artery disease	7.31e-07	8.54e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTGS2—coronary artery disease	6.69e-07	7.81e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPARG—coronary artery disease	6.56e-07	7.66e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—POMC—coronary artery disease	6.47e-07	7.55e-06	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CA—coronary artery disease	6.45e-07	7.53e-06	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CA—coronary artery disease	5.91e-07	6.91e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALB—coronary artery disease	5.9e-07	6.89e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NOS3—coronary artery disease	5.64e-07	6.59e-06	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CA—coronary artery disease	5.28e-07	6.16e-06	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—AKT1—coronary artery disease	5.27e-07	6.15e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTGS2—coronary artery disease	5.16e-07	6.02e-06	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CA—coronary artery disease	5.15e-07	6.02e-06	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CA—coronary artery disease	4.86e-07	5.67e-06	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—AKT1—coronary artery disease	4.83e-07	5.64e-06	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CA—coronary artery disease	4.81e-07	5.62e-06	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—AKT1—coronary artery disease	4.31e-07	5.04e-06	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—AKT1—coronary artery disease	4.21e-07	4.91e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CA—coronary artery disease	4.11e-07	4.8e-06	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—AKT1—coronary artery disease	3.97e-07	4.63e-06	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—AKT1—coronary artery disease	3.93e-07	4.59e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—AKT1—coronary artery disease	3.36e-07	3.92e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CA—coronary artery disease	3.17e-07	3.71e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AKT1—coronary artery disease	2.59e-07	3.03e-06	CbGpPWpGaD
